Medicus Pharma Ltd. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDCX research report →
About the company
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
- CEO
- Raza Bokhari
- IPO
- 2024
- Employees
- 12
- HQ
- W. Conshohocken, CA
Price Chart
- Market Cap
- $9.18M
- P/E
- -0.19
- P/S
- 0.00
- P/B
- 9.27
- EV/EBITDA
- -0.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -4086.31%
- ROIC
- -2193.34%
- Revenue
- $0 · 0.00%
- Net Income
- $-25,366,424 · -127.39%
- EPS
- $-1.96 · -68.97%
- Op Income
- $-18,351,132
- FCF YoY
- -122.27%
- 52W High
- $3.69
- 52W Low
- $0.25
- 50D MA
- $0.34
- 200D MA
- $1.26
- Beta
- -0.65
- Avg Volume
- 4.10M
Get TickerSpark's AI analysis on MDCX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | Smith Andrew Alasdair | other | 200,000 |
| Jun 3, 26 | Rodgers Cathy McMorris | other | 50,000 |
| Jun 3, 26 | Raju Ajay | other | 50,000 |
| Jun 3, 26 | Mehmud Faisal | other | 250,000 |
| Jun 3, 26 | May Sara R. | other | 50,000 |
| Jun 3, 26 | MAHAFFY PATRICK J | other | 50,000 |
| Jun 3, 26 | Kaiser Larry | other | 50,000 |
| Jun 3, 26 | FISHMAN BARRY | other | 50,000 |
| Jun 3, 26 | Ciaruffoli Robert J. | other | 50,000 |
| Jun 3, 26 | Brennan Edward J. | other | 25,000 |
Our MDCX coverage
Recent articles, reports, and earnings notes.
No research on MDCX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDCX report →Similar companies
Peers in the same neighborhood.